Supplement

Beta-Glucans clinical trials

studies test it: 22
open now: 3
in phase 3: 1
first study started: 2001

Keep track of what changes. Save the beta-Glucans studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.

Watch these studies

How studies write it

Studies that test it under each name

Studies by the year they started

22 studies that test it; most in 2018 (4)

Studies that test beta-Glucans, by start year
Year	Studies
2001	1
2004	1
2005	1
2006	1
2007	1
2008	1
2010	1
2013	1
2014	1
2017	1
2018	4
2019	3
2020	1
2022	1
2023	1
2025	2

By phase

A phase 1/2 study counts in both.

Early Phase 1: 1
Phase 1: 4
Phase 2: 6
Phase 3: 1
No phase: 12

What it is tested for

Each study’s main condition, where its own words name it.

Neuroblastoma: 2
Lymphoma: 2
Influenza, Human: 1
Hyperlipidemias: 1
Obesity: 1
Immunologic Deficiency Syndromes: 1
Common Cold: 1
Neoplasms: 1
Melanoma: 1
Carcinoma, Non-Small-Cell Lung: 1
Fatigue: 1
Atherosclerosis: 1

Who runs them

Industry 5 · Other 17

Memorial Sloan Kettering Cancer Center (3) · University of Florida (2) · University of Louisville (2) · OvationLab (1) · USANA Health Sciences (1) · Montreal Heart Institute (1) · Instituto de Ciencia y Tecnología de Alimentos y Nutrición (1) · Kemin Foods LC (1)

Often tested with

Tested in the same studies.

ANTI-GD2 monoclonal antibody 3F8 (2) · Glutamine (2) · Rituximab (2) · Resistant Starch (1) · Lactoferrin (1) · Fructooligosaccharide (1) · Inulin (1) · Pectins (1)

Studies

Open first, then newest update. How each study uses beta-Glucans is read from its arms, and is right about nine times in ten.

Testing it · 22

See all 22 studies that test beta-Glucans →